Geoffrey Oxnard, MD (IMAGE)

Dana-Farber Cancer Institute

Geoffrey Oxnard, MD

Caption

A team of researchers led by Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute has identified multiple types of resistance to new lung cancer drug.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.